(PharmaNewsWire.Com, August 25, 2021 ) According to the new market research report Spirometer Market is projected to reach USD 1,285 million by 2025 from USD 799 million in 2020, at a CAGR of 11.1%.
Growth in this market is largely driven by the rising global incidence of respiratory diseases, increasing aging population, and the technological shift in spirometer devices towards smartphone-based data acquisition. On the other hand, dependence on patient and other human interventions for data will hinder the growth of this market and will remain a challenge.
The spirometer market isconsolidated in nature. The major players operating in this market are Hill Rom (US), Vyaire Medical (US), Fukuda Sangyo (Japan), Chest MI (Japan), Schiller AG (Switzerland), MGC Diagnostics (US), Medical International Research (Italy), ndd Medical Technologies (Switzerland), Vitalograph (UK), and Midmark Corporation (US).
Hill-Rom is the largest player in the spirometer market. The company focuses on the development of devices, consumables, accessories, and software required to perform spirometer tests. These products are sold under the brand Welch Allyn. The company also invests a significant amount on research and development activities.
Vyaire Medical is a pioneer in the spirometer market. As a result, it has a strong foothold in the spirometer devices market. The company was formed by a partnership between BD and Apax Fund Partners, when BD divested its respiratory care business. Apax Fund Partners took over the complete holdings of Vyaire Medical in 2019. Vyaire Medical has a global distribution network and has a good brand reputation among end users.
Based on product, the spirometer market is segmented into devices, consumables & accessories, and software. This segment is expected to witness the highest growth rate during the forecast period.
Based on mechanism, the spirometer market is segmented into flow-sensing spirometer and peak flow meters. The flow- sensing segment accounted for the highest share in 2019.
The global spirometer market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). The North American market is expected to account for the highest market share in 2019. The large share of this market segment can be attributed to the increasing incidence of chronic respiratory diseases and the rising adoption of technologically advanced devices in the region.
Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
